Diabetes is on the rise in children and young people

Published Date: 10 Mar 2023

New findings from researchers at Wake Forest University School of Medicine show that the rate of type 1 and type 2 diabetes is increasing...

Read Full News

Latest News

Modest Protein Restriction Tied to Better Outcomes in CKD

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

Inhaled Insulin Okayed for Kids With Diabetes Aged 6+ Years

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

The Latest in GLP-1-Based Therapy to be Featured at ADA

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

Processed Meat May Raise Gastric and Oesophageal Cancer Risk

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Continuous Glucose Monitoring: Is It Time to Expand Use?

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-Restricted Eating Reshapes Gut Flora, Aids Weight Loss

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Todays Updates

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Snus Linked to Gingival Damage, Raising Safety Questions

Research shows that snus and newer oral nicotine pouches are associated with localized soft tissue changes, prompting greater attention to their oral health effects.

Latest News

A moderately protein-restricted diet is tied to favorable kidney outcomes in patients with chronic kidney disease stage III or IV, according to a recent retrospective study.

The FDA first approved MannKind’s Afrezza for adults with diabetes in 2014.

New receptor agonist combinations, a once-monthly GLP-1, and full retatrutide data are all on the agenda, along with a huge spectrum of other diabetes-related content.

The consumption of processed meat is associated with an increased risk for gastric cancer and oesophageal adenocarcinoma, a multicentre cohort study reports.

Growing evidence suggests that continuous glucose monitoring improves glycemic control, treatment decisions, and patient engagement in people with type 2 diabetes.

Time-restricted eating alters the gut microbiota and serum metabolite profiles in young adults with overweight or obesity, with changes linked to weight loss and improved cardiometabolic health.

News All Time

EMA Panel Backs Weekly Hormone for Child Growth Disorders

European regulators recommend expanding once-weekly growth hormone therapy to include children born small for gestational age and those with Noonan syndrome, potentially reducing injection burden.

Europe Moves Closer to New Retinal Disease Biosimilar

A new anti-VEGF biosimilar has moved closer to European approval for several vision-threatening retinal diseases, including choroidal neovascularization.

Dexcom Warns Patients as Stolen Glucose Sensors Hit the Market

Medical device maker Dexcom said on Tuesday some of its glucose ⁠sensors slated for destruction were instead stolen and sold, prompting the company ⁠to warn users not to use...

Weight Loss Alone May Not Prevent T2D in Some Patients

Prediabetes management often emphasizes weight loss, but a long-term follow-up study found that for some older adults, thinner isn’t always better.

Telephone Weight-Loss Coaching Pays Off in Breast Cancer

Among women with overweight or obesity and early breast cancer, those with the poorest physical function and mental health at baseline appear to benefit the most from telephone weight-loss coaching.

GLP-1s Tied to Weight Loss in Real-World Rheumatologic Care

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

FRAX Predicts Surgery Benefit in Hyperparathyroidism

The Fracture Risk Assessment Tool predictions suggest patients who don’t meet guideline criteria for parathyroidectomy may nevertheless benefit from the surgery.

Serum Acylcarnitines May Predict Kidney Decline in Diabetes

Specific serum acylcarnitine levels are linked to faster kidney function decline in type 2 diabetes and can help improve the prediction of patients at highest risk for rapid decline.

Tirzepatide Yields Early Weight Loss, Later Plateau

Modeling finds marked early weight loss with tirzepatide that later plateaus as appetite returns and energy expenditure decreases, and discontinuation of the drug is linked to partial weight regain.

Stigma Negatively Affects Postbariatric Outcomes

Weight bias, stigma, and discrimination are linked to poorer mental health and weight outcomes after bariatric surgery, although the long-term physical effects remain understudied.

The Sweetener Trap: Are Sugar Alternatives Backfiring?

Emerging evidence suggests some sugar substitutes may affect metabolism, gut microbiome, and cardiovascular health more than previously recognized.

Bayer Says FDA Grants Priority Review Designation for Finerenone

Bayer said on Thursday ⁠that the U.S. Food and ⁠Drug Administration had accepted its ⁠supplemental New ‌Drug Application for finerenone and granted priority review...

BioMarin's Drug Shows Significant Growth Gains in Children in Late-stage Trial

BioMarin Pharmaceutical said on Wednesday its treatment for a rare condition that ⁠leads to short stature helped boost growth in children, meeting the main goal of a...

Diabetic Peripheral Neuropathy Tied to Dementia Risk in T2D

Diabetic peripheral neuropathy above a certain vibration perception threshold is linked to a notably higher risk for dementia in patients with type 2 diabetes, according to a Danish cohort study.

Finding the Next Weight-Loss Drug in Python Blood

Pythons can go weeks without eating. Now researchers have isolated an appetite-suppressing metabolite in python blood that could spur a new weight-loss therapy.

Diabetes Meds Show Varied Associations With Liver Protection

Different antidiabetic drug classes show distinct associations with the risk for major adverse liver outcomes among patients with type 2 diabetes, according to a network meta-analysis.

Recommended News For You

Cancer patients want financial screening early in care, study finds

Charles III, King of Kings, is Cancerous.

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

Alarm Over Pharma-China Link; Taking Screening to the People; Agriculture and Cancer

Radiation from CT scans could account for 5% of all cancer cases a year, study suggests

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

Study supports routine brain MRI screening in asymptomatic late-stage breast cancer patients

Recommended Articles For You

A Visual Guide to Understanding Breast Cancer Staging 

Mastering Oncology RCM: Reducing Errors, Denials & Improving Billing Efficiency 

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians 

Navigating the Complexities of Esophageal Cancer Staging 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

2.

When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.

3.

New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.

4.

Relationship-building key to addressing oncologist shortages in rural care

5.

10-year study shows tomosynthesis improves breast cancer detection

1.

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments

2.

The Role of Calcium Corrections in Accurate Blood Test Results 

3.

A Review of Cancer Treatment Evolution Towards Stem Cells and Gene Therapy

4.

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025

5.

Gynecologic Oncology: Advances, Education, and Clinical Excellence

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

3.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot